ChemInform Abstract: Novel Aryloxyalkylthioimidazoles as Inhibitors of Acyl‐CoA: Cholesterol‐O‐acyltransferase.

Abstract

Novel Aryloxyalkylthioimidazoles as Inhibitors of Acyl-CoA: Cholesterol-O-acyltransferase. -Various title compounds like (III), (V), and (VII) are evaluated for their ability to interfere with the enzyme acyl-CoA. Most of them show a good in vitro ACAT inhibitory activity. (III) and (Va) reduce low density lipoprotein cholesterol levels and increase high density lipoprotein cholesterol levels. -(BANI, M.; BORMETTI, R.; CEC-CARELLI, W.; FIOCCHI, R.; GOBETTI, M.; LOMBROSO, M.; MAGNETTI, S.; OLGIATI, V.; PALLADINO, M.; VILLA, M.; VANOTTI, E.; Eur.